Cannabinoid–Opioid Interactions Differed Between Immune Assays and Pain Responses in Rats

A rat experiment found that combining a cannabinoid agonist with morphine enhanced antinociception without adding to suppression of the measured immune functions. Repeated-exposure interactions also differed between immune and pain-response endpoints.

The immune outcomes were laboratory assays

Researchers used CP-55,940, a synthetic cannabinoid, and morphine. Each reduced stimulated splenocyte proliferation and natural-killer-cell cytolytic activity at the tested doses. These assays describe selected immune functions; they do not directly measure clinical infection risk or the full immune response of a person.

Acute combination effects were not uniform

Coadministration enhanced antinociception but did not produce additive inhibition of the immune parameters. Antagonist comparisons also failed to show that blocking one receptor system simply removed the other drug's central or immune effects. These findings constrain a single shared-pathway explanation.

Cross-resistance depended on what was measured

Animals tolerant to the drugs' antinociceptive effects also developed tolerance to their acute immunosuppressive effects. Cross-resistance appeared for immune suppression, while analgesic cross-tolerance was asymmetric. The abstract does not support treating those patterns as equivalent or assigning an unreported direction to the asymmetry.

This study illustrates why an interaction observed in a pain test cannot automatically be assumed for immune outcomes. It does not establish that marijuana combined with opioids is clinically immunosuppressive, immune-protective or an effective treatment. Compound identity, dosing history and the actual assay remain essential.

Related: interpreting cannabis tolerance claims.

Research cited

Massi P; Vaccani A; Romorini S; Parolaro D. Comparative characterization in the rat of the interaction between cannabinoids and opiates for their immunosuppressive and analgesic effects. Journal of neuroimmunology (2001). doi:10.1016/s0165-5728(01)00323-x. Findings discussed from the study abstract.

Spread the love


The National Black Lawyers

top 40 lawyers

civil trial law

Lawyers of Distinction

Loading...

Recent Blog Articles

Acute THC Altered Adrenal Catecholamine Stores Without a Matching Enzyme Decline

An experimental THC study found lower adrenal-medullary catecholamine stores after acute exposure without a statistically significant decline in a key synthesis enzyme. The changes disappeared with repeated treatment, while circulating hormones followed partly different patterns. Tissue content and enzyme activity were separate measures Acute THC decreased adrenal norepinephrine and epinephrine…

Spread the love

Read Article: Acute THC Altered Adrenal Catecholamine Stores Without a Matching Enzyme Decline

Rimonabant Analogues Produced Cannabinoid-Like Mouse Behaviors Without THC-Like Drug Cues

Some experimental rimonabant analogues produced cannabinoid-like effects in mouse tests but did not reproduce THC's learned drug cue. Other comparisons also separated the compounds from THC, cautioning against equating a similar outward profile with the same pharmacology. Behavioral similarity was only the starting point O-6629 and O-6658 produced dose-dependent effects…

Spread the love

Read Article: Rimonabant Analogues Produced Cannabinoid-Like Mouse Behaviors Without THC-Like Drug Cues

Whole-Brain Receptor Assays Stayed Unchanged Despite Marked THC Behavioral Tolerance in Mice

A mouse study detected substantial THC behavioral tolerance without significant changes in whole-brain receptor binding or mRNA. The result limits a simple whole-brain explanation while leaving regional or functional changes unresolved. Behavior and biochemical assays were different endpoints Mice received THC twice daily for six and a half days. Testing…

Spread the love

Read Article: Whole-Brain Receptor Assays Stayed Unchanged Despite Marked THC Behavioral Tolerance in Mice

Speak with an expert today!

Contact the offices of Okorie Okorocha for professional and reliable advice which you can trust.

Call (424) 363-3347 Contact Us